Phase 4 trial of miltefosine for the treatment of Indian visceral leishmaniasis.


BACKGROUND Visceral leishmaniasis (VL) is a major public health problem in Bihar, accounting for 90% of all cases in India. Development of high levels of resistance to various existing drugs necessitated the search for alternative orally administered drugs. Hospital-based studies have shown that oral miltefosine is a highly effective treatment for VL both… (More)


  • Presentations referencing similar topics